Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valopicitabine is an effective prodrug of the effective anti-HCV drug 2'-C-methylcytidine and can be used as a promising antiviral drug for the study of chronic HCV infection.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,270.00 | |
50 mg | 10-14 weeks | $ 2,980.00 | |
100 mg | 10-14 weeks | $ 4,000.00 |
Description | Valopicitabine is an effective prodrug of the effective anti-HCV drug 2'-C-methylcytidine and can be used as a promising antiviral drug for the study of chronic HCV infection. |
In vivo | In the chimpanzee, Valopicitabine (NM 283) has potent antiviral activity against chronic hepatitis C virus genotype-1 [1].In Sprague-Dawley rats, Valopicitabine exhibits moderate Cmax (3.62 ug/mL) and terminal elimination half-lives (T1/2 0.64 h) following oral administration (100 mg/kg) [2]. |
Synonyms | NM283 |
Molecular Weight | 356.37 |
Formula | C15H24N4O6 |
CAS No. | 640281-90-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valopicitabine 640281-90-9 Microbiology/Virology Proteases/Proteasome HCV Protease NM-283 NM283 NM 283 inhibitor inhibit